Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
Patrick W Serruys, Marie‐Angèle Morel(Ollscoil na Gaillimhe – University of Galway), Ben van Hout(Institute of Technology Assessment), Victor Legrand(Centre Hospitalier Universitaire de Liège), Jean Fajadet(Clinique Pasteur), Ferdinand Kiemeneij(OLVG), Eduardo Sousa(Instituto Dante Pazzanese de Cardiologia), Carlos Macaya(Hospital Clínico San Carlos), Peter Ruygrok(Greenlane Clinical Centre), John Ormiston(Greenlane Clinical Centre), Wim van der Giessen(Rotterdam University of Applied Sciences), Håkan Emanuelsson(AstraZeneca (Sweden)), Ricardo Seabra‐Gomes(Hospital de Santa Cruz), Michael Haude, Hans Bonnier(Catharina Ziekenhuis), Silvio Klugmann(Ospedale Maggiore), Eulogio García(Hospital General Universitario Gregorio Marañón), Antonio Colombo(Memorial Hermann)
Cited by 655
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
|New England Journal of Medicine|1994|4.5k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k